OHSU scientists advance fertility preservation procedure

March 10, 2004

PORTLAND, Ore. --- Scientists at Oregon Health & Science University have significantly advanced a procedure aimed at preserving fertility in female cancer survivors. The research has resulted in the first successful birth of a primate following a procedure called ovarian tissue transplant. The female rhesus monkey was born at the OHSU Oregon National Primate Research Center. Details of this breakthrough are printed in the March 11, 2004, edition of the journal Nature.

"With some of the most successful but aggressive cancer treatments, such as chemotherapy or radiation therapy, up to 90 percent of women prematurely lose the ability to have children," said David Lee, M.D., assistant professor of obstetrics and gynecology, reproductive endocrinology and infertility in the OHSU School of Medicine. Lee is also an assistant professor of pediatrics at the school and first author of the Nature paper. "We believe this breakthrough may be a major step in preserving fertility for young cancer survivors. In the future this procedure could allow a significant number of these cancer survivors to conceive and have healthy children."

Lee collaborated on this research with Don Wolf, Ph.D., a scientist at the ONPRC. Wolf also is a professor of obstetrics and gynecology, and physiology/pharmacology in the OHSU School of Medicine.

To simulate the loss of fertility and the hormone production changes in women battling cancer, the scientists laparoscopically removed the ovaries of seven anesthetized female monkeys. Researchers then transplanted some of each monkeys' own ovarian tissue back into the now infertile animals. The tissue was implanted in the arm, abdomen or kidney. Four monkeys had transplants to both the arm and abdomen, two to the kidney and abdomen, and one to the arm only. The research team then monitored hormone production in the animals and the development of follicles, cavities in the ovarian tissue where eggs (ova) develop.

"What we witnessed in a matter of months was the resumption of hormone cycles very similar to normal fertile animals," explained Wolf. "In addition, some of the monkeys began producing eggs. We then fertilized some of the eggs through intracytoplasmic sperm injection and implanted the resulting embryos in surrogate monkey mothers. Following the normal five-month monkey gestation period, a healthy female infant was born."

The animal's name is BRENDA. Her name stands for Bilateral oophorectomy and Resumption of ENDocrine function with Abdominal follicles and pregnancy.

Previous studies using different methods resulted in hormone production in monkeys. However, until now, no sterile monkey undergoing ovarian tissue transplant has produced fertilizable eggs or offspring.

The oocyte was retrieved seven months after tissue grafting," explained Richard Yeoman, Ph.D., an embryologist at the ONPRC. "Oocyte maturation from the earliest stage normally takes three to four months in humans and monkeys; therefore, this follicle grew and developed entirely after transplantation which is impressive considering the quality of the embryo and the healthy infant."

The researchers suggest that in the case of human treatment, one ovary might be removed at the time cancer is diagnosed in a patient. The ovarian tissue would be frozen and then implanted after the patient was cured of cancer. It is hoped that this tissue would result in normal hormone production and the return of egg production for the patient.

"Once perfected, this procedure would be especially valuable for women battling cancer early in life, between the ages of 10 and 35," added Lee. "The next step is to attempt this procedure using frozen ovarian tissue, mimicking the same conditions required in the case of a cancer patient hoping to re-establish fertility where the patient may wait months to years before attempting to become pregnant."
-end-
Additional OHSU scientists involved in this research include: David Battaglia, Ph.D., Richard Stouffer, Ph.D., Mary Zelinski-Wooten, Ph.D., and John Fanton, D.V.M.

The National Institutes of Health, the Medical Research Foundation, the Autzen Foundation and the American College of Obstetrics and Gynecology funded this research.

The ONPRC is a registered research institution, inspected regularly by the United States Department of Agriculture. It operates in compliance with the Animal Welfare Act and has an assurance of regulatory compliance on file with the National Institutes of Health. The ONPRC also participates in the voluntary accreditation program overseen by the Association for Assessment and Accreditation of Laboratory Animal Care International.

OHSU includes the schools of dentistry, medicine, nursing and science and engineering; OHSU Hospital and Doernbecher Children's Hospital; numerous primary care and specialty clinics; multiple research institutes; and several outreach and community service units.

To view all OHSU press releases, visit www.ohsu.edu.

Oregon Health & Science University

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.